semaglutide week 2 no weight loss 50 mg of oral #semaglutide daily was associated with body reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type #diabetes. https://ja.ma/41sPiYj Woman shares journey of weight

What happened Researchers presenting at ENDO 2026 in Chicago on June 13, 2026 found that adults with obesity who started a GLP-1 receptor agonist drugs like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide, or dulaglutide became noticeably less physically active after beginning treatment

Open communication with healthcare providers ensures safe, effective treatment while minimizing the impact of side effects on patient well-being

An Individualized Approach At Genesis Lifestyle Medicine, we are proud to offer in-person prescriptions for Zepbound in Franklin, TN , as part of our medical weight loss programs

National Heart, Lung, and Blood Institute

doi:10.1007/s13668-022-00441-0 Amrein, Karin et al